Evidence map›Paper›PMID 39896875›Full record

ArticleEClinicalMedicine2025

A core outcome set for maternal and neonatal health research and surveillance of emerging and ongoing epidemic threats (MNH-EPI-COS): a modified Delphi-based international consensus.

Verónica Pingray, Karen Klein, Juan Pedro Alonso, María Belizan, Magdalena Babinska, Jackeline Alger, Hellen C Barsosio, Kara Blackburn, Olufunke Bolaji, Courtney Carson and 30 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Verónica PingrayDepartment of Maternal and Child Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Karen KleinDepartment of Maternal and Child Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Juan Pedro AlonsoUnit of Qualitative Health Research, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
María BelizanUnit of Qualitative Health Research, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Magdalena BabinskaUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Jackeline AlgerDepartamento de Laboratorio Clínico, Hospital Escuela, Tegucigalpa, Honduras.
Hellen C BarsosioCentre for Global Health Research, Maternal and Newborn Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.
Kara BlackburnMaternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, Australia.
Olufunke BolajiNeonatal Unit, Department of Paediatrics and African Neonatal Association, Afe Babalola University, Ado-Ekiti, Nigeria.
Courtney CarsonPandemic Action Network, New York, United States.
Sofia CastiglioniNYU Grossman School of Medicine, New York, NY, USA.
Daniele De LucaDivision of Paediatrics and Neonatal Critical Care, APHP-Paris Saclay University - "A. Béclère" Medical Centre, Paris, France.
Sangappa DhadedDepartment of Neonatology, KLE Academy of Higher Education and Research, JN Medical College, Belgavi, India.
Cyril EngmannMaternal, Newborn, Child Health & Nutrition, PATH, Seattle, United States.
María Fernanda Escobar VidarteUnidad de Equidad Global en Salud, Departamento de Ginecología y Obstetricia, Facultad de Ciencias de la Salud, Fundación Valle del Lili, Cali, Colombia.
Ramón EscurietNational Health Service, Barcelona, Spain.
Edna KaraUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Caron Rahn KimUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Marian KnightNational Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Smaragda LamprianouDepartment of Regulation and Prequalification, Pharmacovigilance Team, World Health Organization, Geneva, Switzerland.
Maria Margarita LotaDepartment of Medical Microbiology, College of Public Health, University of the Philippines, Manila, Philippines.
Silke MaderEuropean Foundation for the Care of Newborn Infants (EFCNI), Munich, Germany.
Lola MadridDepartment of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom.
Alessandra L MarconeNYU Grossman School of Medicine, New York, NY, USA.
Agustina MazzoniDepartment of Maternal and Child Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Rangel Mirna MontenegroObservatory for Sexual and Reproductive Health (OSAR), Guatemala City, Guatemala.
Rose Mukisa-BisoborwaWhite Ribbon Alliance Uganda, Kampala, Uganda.
Flor M MunozDivision of Infectious Disease, and Molecular Virology and Microbiology, Departments of Paediatrics, Baylor College of Medicine, Houston, TX, USA.
Uduak OkomoMedical Research Council (MRC) Unit, London School of Hygiene and Tropical Medicine (LSHTM), Banjul, The Gambia.
Pius OkongUganda Martyrs University (UMU), Nkozi, Uganda.
Vanesa OrtegaDepartment of Maternal and Child Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Florencia A SalvaDepartment of Maternal and Child Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
David A SchwartzPerinatal Pathology Consulting, Atlanta, GA, USA.
Tavitiya SudjaritrukDepartment of Paediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Laura YatesKwaZuluNatal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa.
Manal YounusIraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq.
Noreen ZafarGirls and Women's Health Initiative, Lahore, Pakistan.
Olufemi T OladapoUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Mabel BerruetaDepartment of Maternal and Child Health, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Mercedes BonetUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Disease outbreaks significantly affect maternal and neonatal health. Variability in reporting health outcomes hinder evidence generation. We aimed to develop a core outcome set (COS) for maternal and neonatal health research and surveillance during emerging and ongoing epidemic threats and to agree on outcomes' definitions. Methods: We conducted a systematic review of observational and experimental studies related to epidemics to identify outcomes, and a four-stage modified-Delphi consensus. 150 international stakeholders participated in online surveys, and 24 representatives in consensus meetings. The panels were diverse, with balanced representation of professional background, gender, and geography, including civil society representatives. Outcome were included if ≥ 80% of participants scored them as critically important and ≤10% rated them as not important. Findings: The final COS includes seven main maternal outcomes-pregnancy outcome, maternal death, suspected symptomatic infection, confirmed infection, severe disease, preterm delivery, mode of birth; seven complementary maternal outcomes-antepartum haemorrhage, postpartum haemorrhage, hypertensive disorders of pregnancy, maternal sepsis, admission to intensive care unit/special units, respiratory support, depression and anxiety; 11 main neonatal outcomes-neonatal death, neonatal suspected symptomatic infection, confirmed infection, severe disease, vertical transmission, low birth weight, prematurity, congenital disorder, respiratory support, skin-to-skin contact, breastfeeding; and, four complementary neonatal outcomes-admission to neonatal intensive care unit/special units, respiratory failure, birth asphyxia, sepsis. Interpretation: This COS could contribute to standardize maternal and neonatal outcomes selection and reporting in observational and experimental studies, facilitating efficient data comparison and timely evidence-based decision-making in the context of ongoing and emerging epidemic threats. Funding: Bill & Melinda Gates Foundation (grant INV-041181) and the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (HQHRP2422779).

Indexed as

ConsensusCore outcome setEpidemicsMaternal healthNeonatal health

Identifiers

PMID39896875
PMCPMC11786750

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.